UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000003697
Receipt No. R000004476
Scientific Title Genomics and Neural Function in Irritable Bowel Syndrome
Date of disclosure of the study information 2010/10/01
Last modified on 2020/08/18 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Genomics and Neural Function in Irritable Bowel Syndrome
Acronym Neural Function in IBS
Scientific Title Genomics and Neural Function in Irritable Bowel Syndrome
Scientific Title:Acronym Neural Function in IBS
Region
Japan

Condition
Condition irritable bowel syndorme
Classification by specialty
Medicine in general
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 The purpose of this study is to explore the factors which determines neural response to stimuli in controls and irritable bowel syndrome (IBS).
Basic objectives2 Others
Basic objectives -Others Clarifying pathophysiology of IBS.
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes brain imaging
Key secondary outcomes symptoms
autonomic endocrine response

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Single blind -participants are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 9
Purpose of intervention Prevention
Type of intervention
Medicine Behavior,custom Other
Interventions/Control_1 no stimulus
Interventions/Control_2 mild stimulus
Interventions/Control_3 intense stimulus
Interventions/Control_4 conditioned stimulus
Interventions/Control_5 unconditioned stimulus
Interventions/Control_6 control intervention
Interventions/Control_7 behavioral intervention
Interventions/Control_8 placebo
Interventions/Control_9 agents that modifies stress response
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria healthy controls
IBS diagnosed with Rome III criteria
Key exclusion criteria serious organic disorder
serious psychiatric disorder
Target sample size 800

Research contact person
Name of lead principal investigator
1st name Shin
Middle name
Last name Fukudo
Organization Tohoku University Graduate School of Medicine
Division name Department of Behavioral Medicine
Zip code 980-8575
Address 2-1 Seiryo, Aoba, Sendai 980-8575, Japan
TEL 022-717-8214
Email sfukudo@med.tohoku.ac.jp

Public contact
Name of contact person
1st name Shin
Middle name
Last name Fukudo
Organization Tohoku University Graduate School of Medicine
Division name Department of Behavioral Medicine
Zip code 980-8575
Address 2-1 Seiryo, Aoba, Sendai 980-8575, Japan
TEL 022-717-8214
Homepage URL
Email sfukudo@med.tohoku.ac.jp

Sponsor
Institute Tohoku University Graduate School of Medicine
Institute
Department

Funding Source
Organization JSPS
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethics Committee, Tohoku University Graduate School of Medicine
Address 2-1 Seiryo, Aoba, Sendai 980-8575, Japan
Tel 022-717-8007
Email med-kenkyo@bureau.tohoku.ac.jp

Secondary IDs
Secondary IDs YES
Study ID_1 2009-118/2015-1-084
Org. issuing International ID_1 Ethics Committee, Tohoku University Graduate School of Medicine
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東北大学大学院医学系研究科

Other administrative information
Date of disclosure of the study information
2010 Year 10 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2009 Year 10 Month 01 Day
Date of IRB
2009 Year 07 Month 21 Day
Anticipated trial start date
2010 Year 06 Month 01 Day
Last follow-up date
2020 Year 04 Month 30 Day
Date of closure to data entry
2024 Year 03 Month 31 Day
Date trial data considered complete
2024 Year 03 Month 31 Day
Date analysis concluded
2024 Year 03 Month 31 Day

Other
Other related information

Management information
Registered date
2010 Year 06 Month 02 Day
Last modified on
2020 Year 08 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004476